Telman Deborah H 4

What Happened
Deborah H. Telman, a director of AtriCure, Inc., was granted 6,144 restricted shares on 2026-05-18. The award was granted at $0.00 per share (no cash paid), so the reported acquisition value is $0. This is an equity compensation award (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-05-18; Form 4 filed 2026-05-20 (timely filing).
• Transaction type/code: Award/Grant (A). Price reported: $0.00 per share.
• Shares granted: 6,144. Reported acquisition value: $0.
• Vesting: According to the filing footnote, the shares are restricted and will vest on the one-year anniversary of the grant date under the AtriCure, Inc. 2023 Stock Incentive Plan.
• Shares owned after transaction: Not specified in the filing.
• No tax-withholding or sale noted in this filing.

Context
Restricted stock awards are common executive/director compensation and are typically subject to vesting conditions. Because these shares are restricted until they vest, this grant does not represent an immediate cash investment or an enacted sale; it’s a compensation event and not in itself a clear bullish or bearish signal.